These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22152401)

  • 41. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
    Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder.
    Zilcha-Mano S; Dinger U; McCarthy KS; Barrett MS; Barber JP
    J Affect Disord; 2014 Jan; 152-154():538-42. PubMed ID: 24176534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study.
    Hoffman BM; Babyak MA; Craighead WE; Sherwood A; Doraiswamy PM; Coons MJ; Blumenthal JA
    Psychosom Med; 2011; 73(2):127-33. PubMed ID: 21148807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: results from a randomized trial in Iran.
    Moradveisi L; Huibers MJ; Renner F; Arasteh M; Arntz A
    Behav Res Ther; 2013 Aug; 51(8):499-506. PubMed ID: 23792179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results.
    Schramm E; van Calker D; Dykierek P; Lieb K; Kech S; Zobel I; Leonhart R; Berger M
    Am J Psychiatry; 2007 May; 164(5):768-77. PubMed ID: 17475736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.
    Cuijpers P; Weitz E; Twisk J; Kuehner C; Cristea I; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Faramarzi M; Hegerl U; Jarrett RB; Kennedy SH; Kheirkhah F; Mergl R; Miranda J; Mohr DC; Segal ZV; Siddique J; Simons AD; Vittengl JR; Hollon SD
    Depress Anxiety; 2014 Nov; 31(11):941-51. PubMed ID: 25407584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.
    Binneman B; Feltner D; Kolluri S; Shi Y; Qiu R; Stiger T
    Am J Psychiatry; 2008 May; 165(5):617-20. PubMed ID: 18413705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Major depression and its response to sertraline in primary care vs. psychiatric office practice patients. Results of an open-label trial in Argentina.
    Lyketsos CG; Taragano F; Treisman GJ; Paz J
    Psychosomatics; 1999; 40(1):70-5. PubMed ID: 9989124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31163106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.
    Mao JJ; Xie SX; Zee J; Soeller I; Li QS; Rockwell K; Amsterdam JD
    Phytomedicine; 2015 Mar; 22(3):394-9. PubMed ID: 25837277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of patients' preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder.
    Moradveisi L; Huibers M; Renner F; Arntz A
    J Behav Ther Exp Psychiatry; 2014 Mar; 45(1):170-7. PubMed ID: 24172145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment response in type 2 diabetes patients with major depression.
    Gois C; Dias VV; Carmo I; Duarte R; Ferro A; Santos AL; Sousa F; Barbosa A
    Clin Psychol Psychother; 2014; 21(1):39-48. PubMed ID: 22962030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
    Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
    J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
    Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA; Markowitz JC; Thase ME;
    Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.
    Fann JR; Bombardier CH; Temkin N; Esselman P; Warms C; Barber J; Dikmen S
    J Head Trauma Rehabil; 2017; 32(5):332-342. PubMed ID: 28520672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.